- Home
- PPBT vs ICON Comparison
PPBT vs ICON Comparison
Compare PPBT & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- ICON
- Stock Information
- Founded
- PPBT 2010
- ICON 2023
- Country
- PPBT Israel
- ICON Greece
- Employees
- PPBT N/A
- ICON N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- ICON
- Sector
- PPBT Health Care
- ICON
- Exchange
- PPBT Nasdaq
- ICON Nasdaq
- Market Cap
- PPBT 6.2M
- ICON 5.2M
- IPO Year
- PPBT N/A
- ICON 2024
- Fundamental
- Price
- PPBT $2.31
- ICON $2.24
- Analyst Decision
- PPBT Strong Buy
- ICON Strong Buy
- Analyst Count
- PPBT 1
- ICON 1
- Target Price
- PPBT $33.00
- ICON $4.50
- AVG Volume (30 Days)
- PPBT 269.4K
- ICON 72.2K
- Earning Date
- PPBT 08-06-2025
- ICON 09-09-2025
- Dividend Yield
- PPBT N/A
- ICON 100.00%
- EPS Growth
- PPBT N/A
- ICON N/A
- EPS
- PPBT N/A
- ICON N/A
- Revenue
- PPBT N/A
- ICON $6,137,000.00
- Revenue This Year
- PPBT N/A
- ICON $51.78
- Revenue Next Year
- PPBT N/A
- ICON $51.90
- P/E Ratio
- PPBT N/A
- ICON N/A
- Revenue Growth
- PPBT N/A
- ICON 25.60
- 52 Week Low
- PPBT $2.00
- ICON $1.60
- 52 Week High
- PPBT $13.95
- ICON $130.80
- Technical
- Relative Strength Index (RSI)
- PPBT 49.88
- ICON N/A
- Support Level
- PPBT $2.11
- ICON N/A
- Resistance Level
- PPBT $2.31
- ICON N/A
- Average True Range (ATR)
- PPBT 0.16
- ICON 0.00
- MACD
- PPBT 0.01
- ICON 0.00
- Stochastic Oscillator
- PPBT 72.73
- ICON 0.00
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.